Australia markets open in 3 hours 51 minutes

ResMed Inc. (RMD.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
3,040.000.00 (0.00%)
At close: 11:55AM CST
Currency in MXN

Valuation measures4

Market cap (intra-day) 537.27B
Enterprise value 552.87B
Trailing P/E 27.86
Forward P/E 21.55
PEG ratio (5-yr expected) 1.60
Price/sales (ttm)5.83
Price/book (mrq)5.75
Enterprise value/revenue 7.19
Enterprise value/EBITDA 21.87

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-23.69%
S&P500 52-week change 326.16%
52-week high 34,012.00
52-week low 32,671.39
50-day moving average 33,186.34
200-day moving average 33,320.51

Share statistics

Avg vol (3-month) 32
Avg vol (10-day) 3N/A
Shares outstanding 5146.91M
Implied shares outstanding 6175.25M
Float 8145.47M
% held by insiders 10.82%
% held by institutions 158.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 432.49
Forward annual dividend yield 41.07%
Trailing annual dividend rate 31.88
Trailing annual dividend yield 30.06%
5-year average dividend yield 4N/A
Payout ratio 428.92%
Dividend date 3N/A
Ex-dividend date 408 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.91%
Operating margin (ttm)31.29%

Management effectiveness

Return on assets (ttm)11.91%
Return on equity (ttm)22.39%

Income statement

Revenue (ttm)4.58B
Revenue per share (ttm)31.17
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA 1.44B
Net income avi to common (ttm)958.38M
Diluted EPS (ttm)109.14
Quarterly earnings growth (yoy)29.20%

Balance sheet

Total cash (mrq)259.45M
Total cash per share (mrq)1.77
Total debt (mrq)1.17B
Total debt/equity (mrq)25.21%
Current ratio (mrq)3.04
Book value per share (mrq)31.52

Cash flow statement

Operating cash flow (ttm)1.2B
Levered free cash flow (ttm)955.85M